Meta Pixel

News and Announcements

Market Advantage of Australia’s First Crypto Fund

  • Published November 30, 2017 12:00AM UTC
  • Publisher Wholesale Investor
  • Categories Company Updates

KEY TAKEAWAYS:

  • Rise of cryptocurrency and blockchain in Australia has seen the popularity of fund managers and VCs targeting digital currencies.
  • Australia’s First Crypto Fund are a first-mover in Australia.
  • Global cryptocurrency and blockchain funds have intentions to expand to Australia given the increasing attention it is receiving here.

The rise of cryptocurrency and blockchain in Australia has seen fund managers and VCs switch their attention from traditional equity to these alternate forms of currencies.

Australia’s First Crypto Fund, founded by Dominet Venture Partners’ Domenic Carosa and Holger Arians and Wall Street veteran Henrik Andersson, is striving to attain a minimum of $30 million in digital currencies, ICOs and blockchain-based assets.

Australia’s First Crypto Fund is a first-mover in Australia giving them a great advantage. As the Australian crypto market gains traction, global blockchain funds, such as NEM.io, intend to expand their market to Australia. Mr Carosa of Australia’s First Crypto Fund said that “as the market continued to mature, he expected to see more funds targeting cryptocurrency and blockchain investments…for us, this is part of the market maturing and bringing more credibility to the space.

Australia’s First Crypto Fund will be worth $30 million with a minimum buy-in of $50,000. With success in their sights, the company will allocate some funds to Initial Coin Offerings (ICOs). Blockchain is one of the most compelling technological advancements in today’s society and will assist significantly in reshaping certain industries.

About Australia’s First Crypto Fund

Australia’s First Crypto Fund will invest in a mixture of digital assets, including major cryptocurrencies like Bitcoin and Ethereum, and as well as Initial Coin Offerings (ICOs) and high growth opportunities.

Request Offer

Capital Insights
The Algorithm Re-Dosing Cancer Treatment: Inside the University of Melbourne Spin-Out Rewriting a 60-Year-Old Formula

Oncology specialists are still calculating toxic chemotherapy doses using a formula from the era of the Ford Model T, leading to a system where seven out of eight patients are routinely overdosed. University of Melbourne spin-out PredicTx is dismantling this legacy approach, utilizing advanced AI to analyze existing patient CT scans, deliver precision medicine to the bedside, and return a massive 100x financial rerate to hospital networks.

Join over 45,000+ sophisticated investors

Join Now